Literature DB >> 19901215

Prediction of proliferative diabetic retinopathy with hemoglobin level.

Baqiyyah N Conway1, Rachel G Miller, Ronald Klein, Trevor J Orchard.   

Abstract

OBJECTIVE: To investigate the role of hemoglobin (HGB) level in predicting proliferative diabetic retinopathy (PDR).
METHODS: We assessed 426 individuals without PDR at baseline (213 men; 213 women) from the Pittsburgh Epidemiology of Diabetes Complications Study, an 18-year prospective cohort study of childhood-onset type 1 diabetes. Presence of PDR was determined by stereo fundus photography. Cox proportional hazards modeling with stepwise regression was used to determine the independent association of HGB level with PDR. Analyses were sex specific.
RESULTS: There were 206 events. Although the incidence of PDR did not vary by sex (48% in both men and women), in men, HGB exhibited a positive linear relationship with 18-year incidence of PDR (hazard ratio, 1.33; 95% confidence interval, 1.10-1.60; P = .003), while in women, HGB level exhibited a quadratic relationship with PDR (P < .001). After multivariable adjustment for univariately significant covariates, HGB level remained significantly predictive of PDR in both men (P = .004) and women (P = .04).
CONCLUSION: Higher HGB level predicts the incidence of PDR in type 1 diabetes mellitus, though the association varies by sex, being linear and positive in men and quadratic in women.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19901215      PMCID: PMC2778312          DOI: 10.1001/archophthalmol.2009.274

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  37 in total

1.  [Changes in diabetic retinopathy and visual acuity in patients with end-stage diabetic nephropathy after the introduction of hemodialysis].

Authors:  Miwako Yoshimoto; Shun Matsumoto
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2006-04

2.  Association between higher cumulative doses of recombinant erythropoietin and risk for retinopathy of prematurity.

Authors:  Mark S Brown; Anna E Barón; Eric K France; Richard F Hamman
Journal:  J AAPOS       Date:  2006-04       Impact factor: 1.220

3.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors:  Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

4.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

5.  Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy.

Authors:  Daisuke Watanabe; Kiyoshi Suzuma; Shigeyuki Matsui; Masafumi Kurimoto; Junichi Kiryu; Mihori Kita; Izumi Suzuma; Hirokazu Ohashi; Tomonari Ojima; Tomoaki Murakami; Toshihiro Kobayashi; Seiji Masuda; Masaya Nagao; Nagahisa Yoshimura; Hitoshi Takagi
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

6.  Anemia and diabetes in the absence of nephropathy.

Authors:  Kathrine J Craig; John D Williams; Stephen G Riley; Hilary Smith; David R Owens; Debbie Worthing; Ivor Cavill; Aled O Phillips
Journal:  Diabetes Care       Date:  2005-05       Impact factor: 19.112

7.  The progression of retinopathy over 2 years: the Pittsburgh Epidemiology of Diabetes Complications (EDC) Study.

Authors:  C E Lloyd; R Klein; R E Maser; L H Kuller; D J Becker; T J Orchard
Journal:  J Diabetes Complications       Date:  1995 Jul-Sep       Impact factor: 2.852

8.  Abnormalities in haemorheological factors and lipoprotein (a) in retinal vascular occlusion: implications for increased vascular risk.

Authors:  P L Lip; A D Blann; A F Jones; G Y Lip
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

9.  Sex hormones and the incidence of severe retinopathy in male subjects with type I diabetes.

Authors:  S M Haffner; R Klein; S E Moss; B E Klein
Journal:  Ophthalmology       Date:  1993-12       Impact factor: 12.079

10.  The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes.

Authors:  R Klein; B E Klein; S E Moss; K J Cruickshanks
Journal:  Ophthalmology       Date:  1998-10       Impact factor: 12.079

View more
  9 in total

1.  Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes.

Authors:  Wendy W Harrison; Marcus A Bearse; Jason S Ng; Nicholas P Jewell; Shirin Barez; Dennis Burger; Marilyn E Schneck; Anthony J Adams
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-09       Impact factor: 4.799

2.  Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.

Authors:  Katherine V Williams; Dorothy J Becker; Trevor J Orchard; Tina Costacou
Journal:  J Diabetes Complications       Date:  2019-05-31       Impact factor: 2.852

3.  [Glycated haemoglobin for the diagnosis of diabetes. A universal standard?].

Authors:  Rafael Llanes De Torres
Journal:  Aten Primaria       Date:  2010-04-07       Impact factor: 1.137

4.  Review of therapeutic advances in diabetic retinopathy.

Authors:  Chirag P Shah; Carolyn Chen
Journal:  Ther Adv Endocrinol Metab       Date:  2011-02       Impact factor: 3.565

5.  The Prevalence and Risk Factors of Diabetic Retinopathy: Screening and Prophylaxis Project in 6 Provinces of China.

Authors:  Jiang Liu; Hao Hu; Shanhu Qiu; Duolao Wang; Jianing Liu; Ziwei Du; Zilin Sun
Journal:  Diabetes Metab Syndr Obes       Date:  2022-09-24       Impact factor: 3.249

6.  Association between diabetic retinopathy and hemoglobin level.

Authors:  Adele Bahar; Zahra Kashi; Ahmad Ahmadzadeh Amiri; Majid Nabipour
Journal:  Caspian J Intern Med       Date:  2013

7.  Cross-sectional associations of blood elements, clotting factors, nephropathy, and retinal outcomes in long duration type 1 diabetes.

Authors:  Barbara E K Klein; Ronald Klein; Kerri P Howard; Kristine E Lee
Journal:  Ophthalmic Epidemiol       Date:  2012-06       Impact factor: 1.648

8.  Systemic and ocular diseases associated with the development of diabetic macular edema among Japanese patients with diabetes mellitus.

Authors:  Atsuki Kume; Kenji Kashiwagi
Journal:  BMC Ophthalmol       Date:  2020-07-29       Impact factor: 2.209

9.  Are hemoglobin levels elevated in type 1 diabetes?

Authors:  Baqiyyah N Conway; Rachel G Miller; Trevor J Orchard
Journal:  Diabetes Care       Date:  2009-11-16       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.